References
1-)
Bailey
CJ, Day C. Traditional plant medicines as treatments for diabetes.
Diabetes Care 1989; 12:553.
2-)
Bailey
CJ, Turner RC. Metformin. N Engl J Med 1996; 334:574.
3-)
Salpeter
SR, Greyber E, Pasternak GA, Salpeter EE. Risk of fatal and nonfatal
lactic acidosis with metformin use in type 2 diabetes mellitus. Cochrane
Database Syst Rev 2010; :CD002967.
4-) Graham GG, Punt J, Arora M, Day RO, Doogue MP, Duong JK, Furlong TJ,
Greenfield JR, Greenup LC, Kirkpatrick CM, Ray JE, Timmins P, Williams
KM. Clinical pharmacokinetics of metformin. Clin Pharmacokinet. 2011
Feb;50(2):81-98.
5-)Bailey
CJ, Wilcock C, Day C. Effect of metformin on glucose metabolism in the
splanchnic bed. Br J Pharmacol 1992; 105:1009.
6-)Vecchio
S, Giampreti A, Petrolini VM, et al. Metformin accumulation: lactic
acidosis and high plasmatic metformin levels in a retrospective case
series of 66 patients on chronic therapy. Clin Toxicol (Phila) 2014;
52:129.
7-)Peters N, Jay N, Barraud D, et al. Metformin-associated lactic
acidosis in an intensive care unit. Crit Care . 2008;12(6):R149.
doi:10.1186/cc7137
8-) Ayoub P, Hétu PO, Cormier M, et al. Toxicokinetics of Metformin
During Hemodialysis. Kidney Int Rep . 2017;2(4):759-762. Published
2017 Mar 7. doi:10.1016/j.ekir.2017.02.017